NO20031997L - CRF-reseptor-antagonist og metoder relatert dertil - Google Patents

CRF-reseptor-antagonist og metoder relatert dertil

Info

Publication number
NO20031997L
NO20031997L NO20031997A NO20031997A NO20031997L NO 20031997 L NO20031997 L NO 20031997L NO 20031997 A NO20031997 A NO 20031997A NO 20031997 A NO20031997 A NO 20031997A NO 20031997 L NO20031997 L NO 20031997L
Authority
NO
Norway
Prior art keywords
receptor antagonist
methods related
crf receptor
crf
methods
Prior art date
Application number
NO20031997A
Other languages
English (en)
Other versions
NO20031997D0 (no
Inventor
Mustapha Haddach
Marion C Lanier
Charles Q Huang
James R Mccarthy
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of NO20031997L publication Critical patent/NO20031997L/no
Publication of NO20031997D0 publication Critical patent/NO20031997D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20031997A 2000-11-03 2003-05-02 CRF-reseptor-antagonist og metoder relatert dertil NO20031997D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24582100P 2000-11-03 2000-11-03
PCT/US2001/047919 WO2002040480A2 (en) 2000-11-03 2001-11-02 Crf receptor antagonists and methods relating thereto

Publications (2)

Publication Number Publication Date
NO20031997L true NO20031997L (no) 2003-05-02
NO20031997D0 NO20031997D0 (no) 2003-05-02

Family

ID=22928212

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031997A NO20031997D0 (no) 2000-11-03 2003-05-02 CRF-reseptor-antagonist og metoder relatert dertil

Country Status (11)

Country Link
US (2) US6747034B2 (no)
EP (1) EP1341793B1 (no)
JP (1) JP2004529075A (no)
KR (1) KR20030060927A (no)
AU (2) AU2002239589B2 (no)
CA (1) CA2427656A1 (no)
DE (1) DE60126134T2 (no)
ES (1) ES2279835T3 (no)
MX (1) MXPA03003714A (no)
NO (1) NO20031997D0 (no)
WO (1) WO2002040480A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273871B2 (en) * 2001-07-17 2007-09-25 Sb Pharmco Puerto Rico Inc. Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists
MXPA05007485A (es) 2003-01-14 2006-01-30 Arena Pharm Inc Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
MXPA05013145A (es) * 2003-06-10 2006-03-17 Hoffmann La Roche Derivados de 1,3,4-triaza-fenaleno y 1,3,4,6-tetraazafenaleno.
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
US7132426B2 (en) 2003-07-14 2006-11-07 Arena Pharmaceuticals, Inc. Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
ATE388150T1 (de) * 2003-12-22 2008-03-15 Sb Pharmco Inc Crf-rezeptorantagonisten und diese betreffende verfahren
CA2576435A1 (en) * 2004-08-09 2006-03-23 Research Development Foundation Determination of the 3d-structure of an extracellular domain of a b1 g-protein coupled receptor by nmr analysis
WO2006081522A2 (en) * 2005-01-26 2006-08-03 The Regents Of The Unversity Of California Modulation of nmda receptor currents via orexin receptor and/or crf receptor
PH12013500547A1 (en) 2010-09-22 2013-06-10 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
MX386419B (es) 2015-01-06 2025-03-18 Arena Pharm Inc Metodos de condiciones de tratamiento relacionadas con el receptor s1p1.
EP3939965A1 (en) 2015-06-22 2022-01-19 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid for use in sipi receptor-associated disorders
MA47504A (fr) 2017-02-16 2019-12-25 Arena Pharm Inc Composés et méthodes de traitement de l'angiocholite biliaire primitive
ES2987794T3 (es) 2018-06-06 2024-11-18 Arena Pharm Inc Procedimientos de tratamiento de afecciones relacionadas con el receptor S1P1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129096B1 (en) 1998-11-12 2003-05-21 Neurocrine Biosciences, Inc. Crf receptor antagonists and methods relating thereto
IL142893A0 (en) * 1998-11-12 2002-04-21 Neurocrine Biosciences Inc Fused polyclic heterocyclic compounds and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
EP1341793B1 (en) 2007-01-17
WO2002040480A2 (en) 2002-05-23
MXPA03003714A (es) 2004-05-04
AU3958902A (en) 2002-05-27
US6747034B2 (en) 2004-06-08
CA2427656A1 (en) 2002-05-23
US20020151557A1 (en) 2002-10-17
ES2279835T3 (es) 2007-09-01
AU2002239589B2 (en) 2005-04-21
DE60126134D1 (de) 2007-03-08
NO20031997D0 (no) 2003-05-02
EP1341793A2 (en) 2003-09-10
JP2004529075A (ja) 2004-09-24
WO2002040480A3 (en) 2003-05-15
DE60126134T2 (de) 2007-10-18
US20040266799A1 (en) 2004-12-30
KR20030060927A (ko) 2003-07-16

Similar Documents

Publication Publication Date Title
NO20021361D0 (no) Fremgangsmåte for rask og omfattende formasjonsevaluering
IS7041A (is) 5-HT viðtakabindlar og notkun þeirra
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
NO20024874D0 (no) Benzoamidpiperidin-holdige forbindelser og beslektede forbindelser
NO20024355L (no) Nukleosidforbindelser og anvendelser derav
NO20014553D0 (no) Brönnplanlegging og konstruksjon
DK2325317T3 (da) Receptornukleinsyrer og polypeptidr
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
NO20032668D0 (no) Gyraseinhibitorer og anvendelser derav
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20030471D0 (no) Karboksamidforbindelser og deres anvendelse som antagonister for en 11CBY-reseptor
DK1322597T3 (da) Fremgangsmåde og intermediære
NO20032542L (no) Dempede anti-CD28-antistoffer og anvendelse derav
NO20031997L (no) CRF-reseptor-antagonist og metoder relatert dertil
NO20030228L (no) Antennestruktur og assosiert fremgangsmåte
IS8526A (is) CRF viðtakamótlyf og aðferðir tengdar þeim
NO20030822L (no) Nye forbindelser og fremgangsmåter
IS7438A (is) Lyfjablanda úr PDE4 eða PDE3/4 tálma og histamínviðtakamótlyfi
NO20042500L (no) Chemokin-reseptorantagonister og metoder for anvendelse derav
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter
NO20025135D0 (no) Antihypertensive midler og anvendelse
NO20035319D0 (no) En G-proteinkoblet reseptor og anvendelse derav
ATE474032T1 (de) Fischer-tropsch-verfahren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application